A placebo controlled study of a seven day course of lithium carbonate following myelotoxic chemotherapy.
D000293:Adolescent; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects*; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D007958:Leukocyte Count; D008094:Lithium / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009504:Neutrophils; D010919:Placebos; D013997:Time Factors; D014747:Vinblastine / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D010919:Placebos; D014747:Vinblastine; D004317:Doxorubicin; D008094:Lithium